Literature DB >> 19224636

Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease.

Jayne S Sutherland1, Ifedayo M Adetifa, Philip C Hill, Richard A Adegbola, Martin O C Ota.   

Abstract

Tuberculosis (TB) remains a global health problem. The solution involves development of an effective vaccine, but has been limited by incomplete understanding of what constitutes protective immunity during natural infection with Mycobacterium tuberculosis. In this study, M. tuberculosis-specific responses following an overnight whole-blood assay were assessed by intracellular cytokine staining and luminex, and compared between TB cases and exposed household contacts. TB cases had significantly higher levels of IFN-gamma(+)TNF-alpha(+)IL-2(+)CD4(+)T cells compared with contacts. TB cases also had a significantly higher proportion of cells single-positive for TNF-alpha, but lower proportion of cells producing IL-2 alone and these differences were seen for both CD4(+)and CD8(+) T cells. Cytokine profiles from culture supernatants were significantly biased toward a Th1 phenotype (IFN-gamma and IL-12(p40)) together with a complete abrogation of IL-17 secretion in TB cases. Our data indicate that despite a robust response to TB antigens in active TB disease, changes in the pattern of cytokine production between TB infection and disease clearly contribute to disease progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224636     DOI: 10.1002/eji.200838693

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  94 in total

1.  Tuberculin-specific T cells are reduced in active pulmonary tuberculosis compared to LTBI or status post BCG vaccination.

Authors:  Mathias Streitz; Stephan Fuhrmann; Fiona Powell; Ali Quassem; Laurel Nomura; Holden Maecker; Peter Martus; Hans-Dieter Volk; Florian Kern
Journal:  J Infect Dis       Date:  2010-12-24       Impact factor: 5.226

2.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

Review 3.  Latent tuberculosis: what the host "sees"?

Authors:  Hannah P Gideon; JoAnne L Flynn
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

4.  Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.

Authors:  Yun-Gyoung Hur; Amelia C Crampin; Christina Chisambo; James Kanyika; Rein Houben; Richard Ndhlovu; Themba Mzembe; Maeve K Lalor; Jacky Saul; Keith Branson; Carolynne Stanley; Bagrey Ngwira; Neil French; Tom H Ottenhoff; Hazel M Dockrell; Patricia Gorak-Stolinska
Journal:  Clin Vaccine Immunol       Date:  2013-11-27

5.  A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection.

Authors:  Hongmei Kong; Chunsheng Dong; Sidong Xiong
Journal:  Hum Vaccin Immunother       Date:  2013-11-26       Impact factor: 3.452

6.  Modulation of the immune response to Mycobacterium tuberculosis during malaria/M. tuberculosis co-infection.

Authors:  R C Chukwuanukwu; C C Onyenekwe; L Martinez-Pomares; R Flynn; S Singh; G I Amilo; N R Agbakoba; J O Okoye
Journal:  Clin Exp Immunol       Date:  2016-10-21       Impact factor: 4.330

7.  Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.

Authors:  Thomas J Scriba; Michele Tameris; Nazma Mansoor; Erica Smit; Linda van der Merwe; Fatima Isaacs; Alana Keyser; Sizulu Moyo; Nathaniel Brittain; Alison Lawrie; Sebastian Gelderbloem; Ashley Veldsman; Mark Hatherill; Anthony Hawkridge; Adrian V S Hill; Gregory D Hussey; Hassan Mahomed; Helen McShane; Willem A Hanekom
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

8.  Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection.

Authors:  Ming Zhang; Chunsheng Dong; Sidong Xiong
Journal:  Hum Vaccin Immunother       Date:  2016-12-14       Impact factor: 3.452

9.  Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment.

Authors:  James M Young; Ifedayo M O Adetifa; Martin O C Ota; Jayne S Sutherland
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

10.  Complex cytokine profiles induced by BCG vaccination in UK infants.

Authors:  Maeve K Lalor; Steven G Smith; Sian Floyd; Patricia Gorak-Stolinska; Rosemary E Weir; Rose Blitz; Keith Branson; Paul E Fine; Hazel M Dockrell
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.